Brain delivery and systemic effect of cationic albumin conjugated PLGA nanoparticles

References

• Allemann E, Gurny R, Doelker E. (1992). Preparation of aqueous polymeric nanodispersions by a reversible salting-out process: influence of process parameters on particle size. Int J Pharm, 87, 247–253.
   Web of Science ®Google Scholar
• Bareford LM, Swaan PW. (2007). Endocytic mechanisms for targeted drug delivery. Adv Drug Deliv Rev, 59, 748–758.
   PubMed Web of Science ®Google Scholar
• Begley DJ. (2004). Delivery of therapeutic agents to the central nervous system: the problems and the possibilities. Pharm Ther, 104, 29–45.
   PubMed Web of Science ®Google Scholar
• Bergmann P, Kacenelenbogen R, Vizet A. (1984). Plasma clearance, tissue distribution and catabolism of cationized albumins with increasing isoelectric points in the rat. Clin Sci, 67, 35–43.
   PubMed Web of Science ®Google Scholar
• Bickel U, Yoshikawa T, Pardridge WM. (2001). Delivery of peptides and proteins through the blood–brain barrier. Adv Drug Deliv Rev, 46, 247–279.
   PubMed Web of Science ®Google Scholar
• Bummer PM. (2004). Physical chemical considerations of lipid based oral drug delivery-solid lipid nanoparticles. Drug Carr Syst, 21, 1–20.
   PubMed Web of Science ®Google Scholar
• Davda J, Labhasetwar V. (2002). Characterization of nanoparticle uptake by endothelial cells. Int J Pharm, 233, 51–59.
   PubMed Web of Science ®Google Scholar
• Ellman GL. (1959). Tissue sulfhydryl groups. Arch Biochem Biophys, 82, 70–77.
   PubMed Web of Science ®Google Scholar
• Fundaro A, Cavalli R, Bagoni A, Vighetto D, Zara GP, Gasco MR. (2000). Non-stealth and stealth solid lipid nanoparticles carrying doxorubicin: pharmacokinetic and tissue distribution after i.v. administration to rats. Pharm Res, 42, 337–343.
   Web of Science ®Google Scholar
• Griffin DE, Giffels J. (1982). Study of protein characteristics that influence entry into the cerebrospinal fluid of normal mice and mice with encephalitis. J Clin Invest, 70, 289–295.
   PubMed Web of Science ®Google Scholar
• Gurny R, Peppas NA, Harrington DD, Banker GS. (1981). Development of biodegradable and injectable lattices for controlled release of potent drugs. Drug Dev Ind Pharm, 7, 1–25.
   Web of Science ®Google Scholar
• Huang RQ, Qu Y, Ke W, Zhu J, Pei Y, Jiang C. (2007). Efficient gene delivery targeted to the brain using a transferrin-conjugated polyethyleneglycol-modified polyamidoamine dendrimer. FASEB J, 21, 1117–1125.
   PubMed Web of Science ®Google Scholar
• Huwyler J, Wu D, Pardridge WM. (1996). Brain drug delivery of small molecules using immunoliposomes. Proc Natl Acad Sci USA, 93, 14164–14169.
   PubMed Web of Science ®Google Scholar
• Kumagai A, Eisenberg J, Pardridge W. (1987). Absorptive-mediated endocytosis of cationized albumin and ab-endorphin- cationized albumin chimeric peptide by isolated brain capillaries: model system of blood–brain barrier transport. J Biol Chem, 262, 15214–15219.
   PubMed Web of Science ®Google Scholar
• Lemoine D, Francois C, Kedzierewicz F, Preat V, Hoffman M, Maincent P. (1996). Stability study of nanoparticles of poly(epsiloncaprolactone), poly(d,l-lactide) and poly(d,l- lactide-co-glycolide). Biomaterials, 17, 2191–2197.
   PubMed Web of Science ®Google Scholar
• Lu W, Zhang Y, Tan YZ, Hu KL, Jiang X, Fu S. (2005a). Cationic albumin-conjugated pegylated nanoparticles as novel drug carrier for brain delivery. J Control Release, 107, 428–448.
   PubMed Web of Science ®Google Scholar
• Lu W, Tan Y, Hu K, Jiang X. (2005b). Cationic albumin conjugated pegylated nanoparticle with its transcytosis ability and little toxicity against blood-brain barrier. Int J Pharm, 295, 247–260.
   PubMed Web of Science ®Google Scholar
• Lu W, Wan J, She Z, Jiang X. (2007). Brain delivery property and accelerated blood clearance of cationic albumin conjugated pegylated nanoparticle. J Control Release, 118, 38–53.
   PubMed Web of Science ®Google Scholar
• Mishra V, Mahor S, Vyas SP. (2006). Targeted brain delivery of AZT via transferrin anchored pegylated albumin nanoparticles. J Drug Target, 14, 45–53.
   PubMed Web of Science ®Google Scholar
• Muller RH, Keck CM. (2004). Challenges and solutions for the delivery of biotech drugs—a review of drug nanocrystal technology and lipid nanoparticles. J Biotechnol, 113, 151–170.
   PubMed Web of Science ®Google Scholar
• Olivier JC, Huertas R, Lee H, Calon F, Pardridge WM. (2002). Synthesis of pegylated immunonanoparticles. Pharm Res, 19, 1137–1143.
   PubMed Web of Science ®Google Scholar
• Panyam J, Zhou WZ, Prabha S, Sahoo SK, Labhasetwar V. (2002). Rapid endo-lysosomal escape of poly (DL-lactide-co-glycolide) nanoparticles: implications for drug and gene delivery. FASEB J, 16, 1217–1226.
   PubMed Web of Science ®Google Scholar
• Panyam J, Sahoo SK, Prabha S, Bargar T, Labhasetwar V. (2003). Fluorescence and electron microscopy probes for cellular and tissue uptake of poly (d,l-lactide-co-glycolide) nanoparticles. Int J Pharm, 262, 1–11.
   PubMed Web of Science ®Google Scholar
• Pardridge WM. (1991). Peptide Drug Delivery to the Brain. New York: Raven Press.
   Google Scholar
• Pardridge WM, Triguero D, Buciak JB. (1989). Transport of histone through the blood brain barrier. J Pharmacol Exp Ther, 251, 821–826.
   PubMed Web of Science ®Google Scholar
• Perez C, Sanchez A, Putnam D, Ting D, Langer R, Alonso MJ. (2001). Poly(lactic acid)–poly(ethylene glycol) nanoparticles as new carriers for the delivery of plasmid DNA. J Control Release, 75, 211–224.
   PubMed Web of Science ®Google Scholar
• Prabha S, Labhasetwar V. (2004). Critical determinants in PLGA/PLA nanoparticle-mediated gene expression. Pharm Res, 21, 354–364.
   PubMed Web of Science ®Google Scholar
• Righetti PG, Gianazza E. (1987). Isoelectric focusing in immobilized pH gradients: theory and newer methodology. Methods Biochem Anal, 32, 215–278.
   PubMedGoogle Scholar
• Righetti PG, Gianazza E, Bjellqvist B. (1983). Modern aspects of isoelectric focusing: two-dimensional maps and immobilized pH gradients. Biochem Biophys Methods, 8, 89–108.
   PubMedGoogle Scholar
• Sahoo SK, Panyam J, Prabha S, Labhasetwar V. (2002). Residual polyvinyl alcohol associated with poly (d,l-lactide-co-glycolide) nanoparticles affects their physical properties and cellular uptake. J Control Release, 82, 105–114.
   PubMed Web of Science ®Google Scholar
• Shen WC, Ryser HJP. (1978). Conjugation of poly-L-lysine to albumin and horseradish peroxidase: a novel method of enhancing the cellular uptake of proteins. Proc Natl Acad Sci USA, 75, 1872–1876.
   PubMed Web of Science ®Google Scholar
• Smith MW, Gumbleton M. (2006). Endocytosis at the blood-brain barrier: from basic understanding to drug delivery strategies. J Drug Target, 14, 191–214.
   PubMed Web of Science ®Google Scholar
• Thöle M, Nobmann S, Huwyler J, Bartmann A, Fricker G. (2002). Uptake of cationized albumin coupled liposomes by cultured porcine brain microvessel endothelial cells and intact brain capillaries. J Drug Target, 10, 337–344.
   PubMed Web of Science ®Google Scholar
• Vorbrodt AW. (1989). Ultracytochemical characterization of anionic sites in the wall of brain capillaries. J Neurocytol, 18, 359–368.
   PubMedGoogle Scholar
• Xie Y, Lu W, Jiang X. (2006). Improvement of cationic albumin conjugated pegylated nanoparticles holding NC-1900, a vasopressin fragment analog, in memory deficits induced by scopolamine in mice. Behav Brain Res, 173, 76–84.
   PubMed Web of Science ®Google Scholar
• Yuan J. (1993). Estimation of variance for AUC in animal studies. J Pharm Sci, 82, 761–763.
   PubMed Web of Science ®Google Scholar
• Zhang Y, Zhang Q, Zha L, Yang W, Wang C, Jiang X, Fu S. (2004). Preparation, characterization and application of pyrene-loaded methoxy poly (ethylene glycol)-poly(lactic acid) copolymer nanoparticles. Colloid Polym Sci, 282, 1323–1328.
   Web of Science ®Google Scholar